Recombinant human thyroid-stimulating hormone (rhTSH): Clinical development

Journal of Endocrinological Investigation

Volumn 22, Issue 11 SUPPL. 1, 1999, Pages 8-16

  Incerti, C ^a,b  

^a Medical Clinical and Regulatory Affairs   (Netherlands)

^b Embit srl   (Italy)

Author keywords

Diagnostic I 131 whole body scanning (WBS); Recombinant human thyroid stimulating hormone (rhTSH); Serum thyroglobulin (Tg) testing

Indexed keywords

ANTITHYROID AGENT; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RECOMBINANT PROTEIN; THYROGLOBULIN; THYROTROPIN;

BLOOD; HUMAN; PHASE 3 CLINICAL TRIAL; REVIEW; THYROID TUMOR; TUMOR RECURRENCE;

ANTITHYROID AGENTS; CLINICAL TRIALS, PHASE III; HUMANS; IODINE RADIOISOTOPES; NEOPLASM RECURRENCE, LOCAL; RECOMBINANT PROTEINS; THYROGLOBULIN; THYROID NEOPLASMS; THYROTROPIN;

EID: 0033251260     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Schlumberger M., Pacini F. Thyroid Tumors. Editions Nucléon, Paris, 1999, p. 1.
2. Pacini F., Cetani F., Miccoli P., Mancusi F., Ceccarelli C., Lippi F., Martino E., Pinchera A. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J. Surg. 1994, 18: 600.
3. Mazzaferri E.L., Jhiang S.M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 1994, 97: 418.
4. Schlumberger M.J. Papillary and follicular thyroid carcinoma [Medical progress]. N. Engl. J. Med. 1998, 338: 297.
5. Høie J., Stenwig, A.E., Kullmann G., Lindegaard M. Distant metastases in papillary thyroid cancer: a review of 91 patients. Cancer 1988, 67: 1.
6. Ozata M., Suzuki S., Miyamoto T., Liu R.T., Fierro-Renoy F., DeGroot L.J. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 1994, 79: 98.
7. Schlumberger M.J., Baudin E. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma. Eur. J. Endocrinol. 1998, 138: 249.
8. 131I uptakes after triiodothyronine withdrawal in patients with thyroid cancer. J. Clin. Endocrinol. Metab. 1981, 53: 1199.
9. Maini C.L., Sciuto R., Tofani A. Delayed thyroid-stimulating hormone suppression by L-thyroxine in the management of differentiated thyroid cancer [letter]. Eur. J. Cancer 1993, 29A: 2072.
10. Krishnamurty G.T. Human reaction to bovine TSH: concise communication. J. Nucl. Med. 1978, 19: 284.
11. Hays M.T., Solomon D.H., Beall G.N. Suppression of human thyroid function by antibodies to bovine thyrotropin. J. Clin. Endocrinol. Metab. 1967, 27: 1540.
12. Schlumberger M., Charbord P., Fragu P., Gardet P., Lumbroso J.D., Parmentier C., Tubiana M. Relationship between thyrotropin stimulation and radioiodine uptake in lung metastases of differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 1983, 57: 148.
13. Thotakura N.R., Desai R.K., Bates L.G., Cole E.S., Pratt B.M., Weintraub B.D. Biological activity and metabolic clearance of a recombinant thyrotropin produced in Chinese hamster ovary cells. Endocrinology 1991, 128: 341.
14. Kashiwai T., Ichihara K., Endo Y., Tamaki H., Amino N., Miyai K. Immunological and biological characteristics of recombinant human thyrotropin. J. Immunol. Methods 1991, 143: 25.
15. Huber G.K., Fong P., Concepcion E.S., Davies T.F. Recombinant human thyroid-stimulating hormone: initial bioactivity assessment using human fetal thyroid cells. J. Clin. Endocrinol. Metab. 1991, 72: 1328.
16. Szkudlinski M.W., Thotakura N.R., Bucci I., Joshi L.R., Tsai A., East-Palmer J., Shiloach J., Weintraub, B.D. Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity. Endocrinology 1993, 133: 1490.